semaglutide deals Trump announces deal to lower cost of weight loss drug Half-off Ozempic deal sends Novo

And you had circadian rhythms

Emily Cooper, Mark Wright, and Andrea Taylor explore the research proving GLP-1 medications are far more than "weight loss drugs." The team explains how cardiovascular outcome trials revealed unexpected heart protection, why inflammation reduction may be the real mechanism behind these benefits, and what the latest FDA approvals for kidney disease, sleep apnea, and fatty liver mean for patients

Melanotan II is sold as a sunless tan hack, but the risk list is longer than most people expect, and the long-term story still has big blanks

El-Sayed Moustafa, J

Proc Natl Acad Sci USA (2020) 117(11):605666